肝酶和血液参数与在良性和恶性肝损伤中的组织病理严重性的相关性
Umair Toqueer1, Abdul Manan2, Anila Riyaz3
1Medicine, Pinderfields Hospital, Wakefield, GBR.
Cureus
|October 24, 2025
概括
肝酶和血液细胞计数可以帮助区分良性和恶性肝病变. 肝酶和特定血液标记物的升高与恶性瘤和疾病严重程度相关,有助于早期检测.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 临床生物化学 临床生物化学
背景情况:
- 肝病变往往缺乏特定的临床症状,使诊断和预后复杂化.
- 组织病理学是明确的,但需要非侵入性生物标志物来评估严重程度.
研究的目的:
- 评估肝酶和血液学标志物,以区分良性与恶性肝病变.
- 为了将这些标记与肝脏病变中的组织病理严重程度相关联.
主要方法:
- 对120名肝损伤患者进行前性观察性研究.
- 分析肝酶 (ALT,AST,ALP,胆红素) 和血液学参数 (血红蛋白,白细胞,血小板,ESR).
- 使用统计分析与组织病理学分级的相关性.
主要成果:
- 与良性病变相比,恶性病变的ALT,AST,ALP, bilirubin,白细胞计数和ESR显著更高 (p < 0.001).
- 在恶性病变中,血红蛋白水平显著降低 (p < 0.001).
- 标记物与恶性瘤等级相关,对ALT,AST,ALP,ESR具有强烈的正相关性,对血红蛋白负相关性.
结论:
- 肝酶和血液学标记物对肝损伤具有显著的诊断和预后效用.
- 整合这些标记可以改善早期检测,特别是在资源有限的环境中.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Liver Histology
4.0K
The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Hepatocytes perform a variety of essential functions. They secrete...
4.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
211
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
211
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K


